Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine

SIMPLE SUMMARY: V-306 is a synthetic virus-like particle-based vaccine candidate displaying multiple respiratory syncytial virus (RSV) F site II protein mimetics (FsIIm) as an antigenic epitope. This first-in-human, double-blind, placebo-controlled, dose-escalating study in healthy young women showe...

Descripción completa

Detalles Bibliográficos
Autores principales: Leroux-Roels, Isabel, Bruhwyler, Jacques, Stergiou, Lilli, Sumeray, Mark, Joye, Jasper, Maes, Cathy, Lambert, Paul-Henri, Leroux-Roels, Geert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967611/
https://www.ncbi.nlm.nih.gov/pubmed/36851245
http://dx.doi.org/10.3390/vaccines11020367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967611/
https://www.ncbi.nlm.nih.gov/pubmed/36851245
http://dx.doi.org/10.3390/vaccines11020367

Ejemplares similares